| |
|
| |
| THE GENERAL ASSEMBLY OF PENNSYLVANIA |
| |
| SENATE BILL |
|
| |
| |
| INTRODUCED BY FARNESE, FONTANA, ERICKSON, BAKER, COSTA, WOZNIAK, WASHINGTON, HUGHES, WILLIAMS, KITCHEN, BLAKE AND YUDICHAK, APRIL 4, 2011 |
| |
| |
| REFERRED TO JUDICIARY, APRIL 4, 2011 |
| |
| |
| |
| AN ACT |
| |
1 | Amending the act of April 14, 1972 (P.L.233, No.64), entitled |
2 | "An act relating to the manufacture, sale and possession of |
3 | controlled substances, other drugs, devices and cosmetics; |
4 | conferring powers on the courts and the secretary and |
5 | Department of Health, and a newly created Pennsylvania Drug, |
6 | Device and Cosmetic Board; establishing schedules of |
7 | controlled substances; providing penalties; requiring |
8 | registration of persons engaged in the drug trade and for the |
9 | revocation or suspension of certain licenses and |
10 | registrations; and repealing an act," further providing for |
11 | schedules of controlled substances. |
12 | The General Assembly of the Commonwealth of Pennsylvania |
13 | hereby enacts as follows: |
14 | Section 1. Section 4(1)(iii) of the act of April 14, 1972 |
15 | (P.L.233, No.64), known as The Controlled Substance, Drug, |
16 | Device and Cosmetic Act, amended November 24, 1999 (P.L.894, |
17 | No.55), is amended to read: |
18 | Section 4. Schedules of Controlled Substances.--The |
19 | following schedules include the controlled substances listed or |
20 | to be listed by whatever official name, common or usual name, |
21 | chemical name, or trade name designated. |
22 | (1) Schedule I--In determining that a substance comes within |
|
1 | this schedule, the secretary shall find: a high potential for |
2 | abuse, no currently accepted medical use in the United States, |
3 | and a lack of accepted safety for use under medical supervision. |
4 | The following controlled substances are included in this |
5 | schedule: |
6 | * * * |
7 | (iii) Any material, compound, mixture, or preparation which |
8 | contains any quantity of the following hallucinogenic |
9 | substances, their salts, isomers, and salts of isomers, unless |
10 | specifically excepted, whenever the existence of such salts, |
11 | isomers, and salts of isomers is possible within the specific |
12 | chemical designation: |
13 | 1. 3,4-methylenedioxy amphetamine. |
14 | 2. 5-methoxy-3,4-methylenedioxy amphetamine. |
15 | 3. 3,4,5-trimethoxy amphetamine. |
16 | 4. Bufotenine. |
17 | 5. Diethyltryptamine. |
18 | 6. Dimethyltryptamine. |
19 | 7. 4-methyl-2,5-dimethoxyamphetamine. |
20 | 8. Ibogaine. |
21 | 9. Lysergic acid diethylamide. |
22 | 10. Mescaline. |
23 | 11. Peyote. |
24 | 12. N-ethyl-3-piperidyl benzilate. |
25 | 13. N-methyl-3-piperidyl benzilate. |
26 | 14. Psilocybin. |
27 | 15. Psilocyn. |
28 | 16. Tetrahydrocannabinols. |
29 | 17. 3,4-methylenedioxymethcathinone. |
30 | 18. 3,4-methylenedioxypyrovalerone. |
|
1 | 19. 4-methylmethcathinone. |
2 | 20. 3-methoxymethcathinone. |
3 | 21. 3-fluoromethcathinone. |
4 | 22. 4-fluoromethcathinone. |
5 | * * * |
6 | Section 2. This act shall take effect in 60 days. |
|